Home ::

Prostate Cancer Chemotherapy News

Prostate Cancer Chemotherapy - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
Medivation Surges on
Men with read more...
J&J’s Zytiga for
The drug, also known as abiraterone, won approval in the European Union last year for use in combination with prednisone or prednisolone for men whose read more...
Phil Burr, chair of the West Wales read more...
Closing the Global
Overall, treatment success has increased dramatically, with survival rates in high income countries like the U.S. now reaching over 90 percent for certain read more...
Medivation and Astellas Announce Positive Results From the Phase 3 AFFIRM Trial of MDV3100 in
SAN FRANCISCO, CA and TOKYO--(Marketwire -01/31/12)- Medivation, Inc. (NASDAQ: MDVN - News) and Astellas Pharma Inc. (Tokyo: 4503) announced positive results on all efficacy endpoints from the Phase 3 AFFIRM trial of the investigational drug ... read more...
These significant benefits in the ALSYMPCA (Alpharadin in Symptomatic read more...